Position:
Professor
Division:
Respiratory
Education:
MB BCH BAO, University College, Dublin, Medicine
Doctorate Equivalent (PhD), University College, Dublin, Ireland,
FRCP I, College of Physicians of Ireland
FRCPC, College of Physicians, Canada
Recent Publications:
  • •Aaron SD, Fergusson D, Marks G, Suissa S, Vandemheen KL, Doucette S, Maltais F, Bourbeau J, Goldstein R, Balter M, O’Donnell D, FitzGerald M. Counting , analyzing and reporting exacerbations of COPD in randomized controlled trials. Thorax 2008;63 122-128.
  • •Aaron SD, Vandemheen KL, Boulet L-P, McIvor RA, FitzGerald JM, Hernandez P, Lemiere C, Sharma S, Field SK, Alvarez G, Dales RE, Doucette S, Fergusson D for the Canadian Respiratory Clinical Research Consortium (CRCRC). Misclassification of Asthma in Obese and Non-Obese Adults. CMAJ 2008; 179:1121-31.
  • •Al Lawati N, FitzGerald JM. Acute exacerbation of chronic obstructive pulmonary disease. BC Medical Journal 2008; 50:144-148.
  • •Balter M, Ernst P, Watson W, Kim H, Cicutto L, Beauchesne M-F, Cave A, Kaplan A, McIvor A, Smile T, Rouleau M, FitzGerald JM. Asthma worsenings: approaches to prevention and management from the Asthma Worsenings Working Group. CRJ 2008;15.(supple) 1B-17B.
  • •Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O’Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31:143-178.
  • •Boulet LP, FitzGerald JM, McIvor RA, Zimmerman S, Chapman KR. Influence of current or former smoking on asthma management and control. Can Resp J 2008; 15: 275-279.
  • •Burney P, Potts J, Aït-Khaled N, Sepulveda RMD, Zidouni N, Benali R, Jerray M, Musa OAA, El-Sony A, Behbehani N, El-Sharif N, Mohammad Y, Khouri A, Paralija B, Eiser N, Fitzgerald M, Abu-Laban R. A multinational study, of treatment failures in asthma management. Journal of IUATLD 2008; 12:13-18.
  • •Etiman M, Sadatsafavi M, Zavareh SG, Takbouche B, FitzGerald JM. Inhaled Corticosteroids and the Risk of Fractures in Older Adults. Drug Safety 2008;31 :409-414.
  • •Finley C, Clifton J, FitzGerald JM, Yee J.  Empyema: an increasing concern in Canada. Can Resp J 2008; 15:85-89.
  • •FitzGerald JM. COPD in primary care: a case based review. The Canadian Journal of CME. 2008;20:38-40.
  • •Fitzgerald JM. The challenge of managing multiple drug  resistant tuberculosis. CRJ 2008;17:8C-9C.
  • •Fok A, Numata Y, Schulzer M, FitzGerald JM. Risk factors for clustering of tuberculosis cases: a systematic review of population based molecular epidemiology studies. Int Journal Tuberc lung Dis 2008; 12:480-492.
  • •Guo N, Marra CA, Marra F, Moadebi S, Elwood RK, Fitzgerald JM. Health utilities in latent and active tuberculosis. Value Health 2008;11:1154-1161.
  • •Lomas D et al and the ECLIPSE Investigators. Evaluation of serum CC-16 as a biomarker for chronic obstructive pulmonary disease in the ECLIPSE cohort. Thorax 2008; 63:1058-1063.
  • •Marra CA, Marra F, Y Colley L, Moadebi S, Elwood RK, Fitzgerald JM. Health-Related Quality of Life Trajectories Among Adults With Tuberculosis: Differences Between Latent and Active Infection. Chest,  2008; 133: 396 – 403.
  • •Marra CA, Najafzadeh M, Sadatsafavi M, Aaron S, Vandemheem KL, Sullivan S, Jones PW, Fitzgerald JM. Cost-Effectiveness of Therapy with Combinations of Long-Acting Bronchodilators and Inhaled Steroids for Treatment of COPD: An Economic Evaluation. Thorax 2008 (in press).
  • •Marra F, Marra C, Sadatsafavui M, Moran-Mendoza-Mendoza O, Cook V, Elwood K, Morshed M, RC Brunham RC, FiitzGerald JM. Cost Effectiveness of a new interferon based blood assay (Quantiferon-TB Gold) in screening tuberculous contacts. Int J Tuberc And lung Dis 2008;12:1414-1424. (in press).
  • •McTaggart-Cowan HM, Marra CA, Yang Y, Brazier JE, Kopec JA, Fitzgerald JM, Anis A, Lynd LD. An evaluation of patient’s willingness to trade symptom-free days for asthma related treatment risks: a discrete choice experiment. Journal of Asthma 2008;45: 630-638.
  • •McTaggart-Cowan HM, Marra CA, Yang Y, Brazier JE, Kopec JA, Fitzgerald JM, Anis A, Lynd LD. The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status. Quality of Life Research 2008; 17:453-462.
  • •Miller E, FitzGerald JM. Budesonide/Formoterol as Maintenance and Reliever Treatment Compared to Fixed Dose Combination Strategies – A Canadian Economic Evaluation. Can J Clinical Pharmacology 2008;15:165-176.
  • •Mittmann N, Kuramoto L, Seung SJ, Haddon JM, Bradley-Kennedy C, FitzGerald JM. The cost of moderate and sever COPD exacerbations to the Canadian health care system. Resp Med 2008; 102-3:413-421.
  • •Mulgrew AT, Ryan CF, Fleetham JA, Cheema R, Fox N, Koehoorn M, FitzGerald JM, Marra C, Ayas NT. The Impact of Obstructive Sleep Apnea and Daytime Sleepiness on Work Limitation. Sleep Medicine. 2008; 9: 42-53.
  • •Sears MR, Boulet LP, Laviolette M, FitzGerald JM, Bai TR, Kaplan A, Smiljanic-Georgijev N, Lee J. Budesonide/formoterol as maintenance and reliever therapy for asthma: efficacy compared with conventional best practice and impact on airway inflammation. Eur Resp J 2008;31:982-989.
  • •Sin D, Man P, Marciniuk D, Ford G, FitzGerald M, Wong E, York E Mainra, Ramesh R, Melenka L, Wilde E, Cowie R, Williams D, Rousseau R. On behalf of the ABC (Advair, Biomarkers in COPD) Investigators The Effects of Fluticasone With or Without Salmeterol On Systemic Biomarkers of Inflammation in COPD.  Am J Respir Crit Care 2008; 177: 1207-1214.
  • •Sobolev B, Sanchez V, Kuramoto L, Levy AR, Schechter M, FitzGerald JM. Evaluation of booking systems for elective surgery using simulation experiments. Health Care Policy 2008; 3: 113-124.
  • •Sobolev BG, Fradet G, Hayden R,  Kuramoto L, Levy AR, Fitzgerald JM. Delay in admission for elective coronary-artery bypass grafting is associated with increased in-hospital mortality. BMC Health Services Research 2008.
  • •Sobolev BG, Fradet G, Hayden R, Kuramoto L, Levy AR, FitzGerald JM. Survival benefit of coronary-artery bypass grafting accounted for deaths in those who remained untreated. Journal of Cardiothoracic Surgery 2008; 3:47.
  • •Takkouche B, González-Barcala FJ, Etminan M, FitzGerald JM. Exposure to furry pets and the risk of asthma and allergic rhinitis: A meta-analysis. Allergy 2008 ;63:857-864.
  • •Tan MC, Marra CA, Sadatsafavi M, Marra F, Moran Mendoza O, Moadebi S, Elwood RK, Fitzgerald JM. Cost effectiveness of LTBI treatment for TB contacts in British Columbia. Value in health 2008. ePub ahead of print in May.
  • •Tan MCY, Ayas N, Mulgrew A, Cortes L, FitzGerald JM, Fleetham J, Schulzer M, Ryan CF, Ghael R, Cooper P, Marra CA. Cost effectiveness of continuous positive pressure therapy in patients with obstructive apnea- hypopnoea in British Columbia. Can Respir J 2008; 15:159-165.
  • •Van der Wal R, Globerman J, Numata Y, Schulzer M, FitzGerald JM, Yassi A. Part 1: Improving the bpractice environment: A pilot project in a critical care unit. Healthcare Management: Forum. 2008; 27-33.
  • •Vestbo, J Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G,  Knobil GA, Lomas D, MacNee W, Silverman EK, Tal-Singer R. On behalf of the ECLIPSE investigators Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 2008; 31:869-873.
  • •Bahadori, K Doyle-Waters, M Marra,C  Lynd, L Alasaly,K Swiston,J FitzGerald, JM.  Economic burden of asthma: a systematic review. BMC Pulm Med. 2009; 9: 24. Published online 2009 May 19. doi: 10.1186/1471-466-9-24.
  • •Bahadori K, FitzGerald JM, Levy RD, Fera T, Swiston J. Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization Can Resp J 2009; 16: e43-e49.
  • •Etminan M, levesque L, Fitzgerlad JM, Brophy JM. Risk of upper gastro intestinal bleeding with oral biphosphonates and non steroidal anti inflammatory drugs: a case control study. Alimnet Pharmacol Ther 2009;29: 1188-92.
  • •Etminan M, Sadatsafavi M, Jafari S, Doyle-Waters M, Aminzadeh K, Fitzgerald JM. Acetaminophen Use and the Risk of Asthma in Children and Adults: A Systematic Review and Meta-analysis. Chest. 2009.
  • •FitzGerald JM, Foucart S, Coyle S, Sampalis J, Haine D, Psaradellis E, McIvor RA. Montelukast as add-on therapy to inhaled corticosteroids in the management of asthma (the SAS trial).Can Respir J. 2009 16 Suppl A: 5A-14A.
  • •Janda S, Park K, FitzGerald JM, Etminan M, Swiston J. Statins in COPD: A Systematic Review. Chest  2009;136:734-743.
  • •Johnston, JC Shahidi NC, Sadatsafavi, M FitzGerald JM. Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis. PLoS 2009.
  • •O’Byrne PM Linde J van der, Cockcroft DW, Gauvreau GM, Brannan JD, FitzGerald JM, Watson RM, Milot J, Davis B, O’Connor M, Hart L, Korducki L,  Hamilton AL Boulet L-P. Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting ß2-agonist, in mild asthmatics. JACI 2009 (in press).
  • •Tan WC, Lo C, Jong A, Xing L, Wang E, FitzGerald MJ, Vollmer W, Buist S, Sin D. Mariijuana and chronic obstructive lung disease: a population based study. CMAJ 2009; 180 :814-20.
  • •The Impact of Prolonged Continuous Wakefulness on Resident Clinical Performance in the Intensive Care Unit: A Patient Simulator Study. Crit Care med 2009 (in press).
  • •Yamada S, Richardson K, Halaschek-Wiener J, Chan M, Cook VJ, Fitzgerald JM, Elwood RK, Brooks-Wilson A, Marra F. genetic variation of NAT2 and CYP2E1 and isoniazid hepatotoxicty in a diverse population. Pharmacogenomics 2009; 10: 1433-1445.
  • •Sadatsafavi M, Shahidi N, Marra F, Fitzgerald MJ, Elwood KR, Guo N, Marra CA.A statistical method was used for the meta-analysis of tests for latent TB in the absence of a gold standard, combining random-effect and latent-class methods to estimate test accuracy. J Clin Epidemiol. 2009 Aug 17.
  • •FitzGerald JM, Shahidi N. Achieving asthma control in patients with moderate disease. J Allergy Clin Immunol 2010 Feb; 125(2):307-11.
  • •Sadatsafavi M, Lynd LD, Marra CA, Carleton B, Tan WC, FitzGerald JM. Direct health care costs associated with asthma in British Columbia. Can Respir J. 2010 Mar/Apr;17(2):74-80.
  • •Sadatsafavi M, Shahidi N, Marra F, FitzGerald JM, Elwood RK, Guo N, Marra CA. A random-effects latent-class model for the meta-analysis of the accuracy of screening tests for latent tuberculosis in the absence of a gold standard. J Clin Epi 2010 Mar 63; 257-269.
  • •Bahadori K, Quon BS, Doyle-Waters MM, Marra C, FitzGerald JM. A systematic review of economic evaluations of therapy in asthma. Journal of Asthma and Allergy 2010:3 33-42.
  • •Basanta M, Jarvis RM, Xu Y, et al. Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers. Analyst 2010; 135: 315-320.
  • •Cho MH, Boutaoui N, Klanderman BA, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genetics 2010;42: 200-202.
  • •FitzGerald JM, Quon B. The impact of asthma guidelines. Comment. Lancet 2010.
  • •Foreman MG,  Kong X, DeMeo DL, et al. Polymorphisms in surfactant protein D are associated with COPD. Am J Respir Crit Care Med 2010; Epub ahead of print.
  • •Guo N, Marra F, Fitzgerald JM, Elwood RK, Marra CA. Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis. Eur Respir J. 2010 l;36:206-8.
  • •Hodder R, Lougheed D, Rowe BH, FitzGerad JM, Kaplan AG, McIvor RA. Management of acute asthma in adults in the emergency department: assisted ventilation. CMAJ 2010; 182(3): 265-72.
  • •Hodder R, Lougheed D, Rowe BH, FitzGerad JM, Kaplan AG, McIvor RA. Management of acute asthma in adults in the emergency department: nonventilatory management. CMAJ 2010; 182: E55-67.
  • •Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in Chronic Obstructive Pulmonary Disease. N Eng J Med 2010;363:1128-1138.
  • •Janda S, Young A, Fitzgerald JM, Etminan M, Swiston J. The effect of statins on mortality from severe infections and sepsis: A systematic review and meta-analysis. J Crit Care 2010; 25: 656.
  • •Lougheed MD, Lemière C, Dell SD, Ducharme FM, Fitzgerald JM, Leigh R, Licskai C, Rowe BH, Bowie D, Becker A, Boulet LP. Canadian Thoracic Society Asthma Committee commentary on long-acting beta-2 agonist use for asthma in Canada. Can Respir J 2010:17):57-58.
  • •Lougheed MD, Lemière C, Dell SD, Ducharme FM, Fitzgerald JM, Leigh R, Licskai C, Rowe BH, Bowie D, Becker A, Boulet LP. Canadian Thoracic Society Asthma Management Continuum – 2010 Consensus Summary for children six years of age and over, and adults. Can Respir J   2010 :17:15-24.
  • •Moran-Mendoza O, Marion SA, Elwood K, Patrick D, FitzGerald JM. Risk factors for developing tuberculosis: a 12-year follow-up of contacts of TB cases.  Int J of Tub  lung dis 2010; 14(9):1112-1119.
  • •Pakhale S, Doucette S, Vandemheen K,  Boulet L-P, McIvor RA, FitzGerald JM, Hernandez P, Lemiere C, Field SK, Alvarez G, Dales RE, Aaron SD. A comparison of obese and nonobese asthmatics: Exploring an asthma-obesity interaction. Chest 2010 137:1316-23.
  • •Shahidi N, FitzGerald JM. Current recommendations for the treatment of mild asthma.Journal of Asthma and Allergy; 2010: 169 – 176.
  • •Sharpe R, Koval V, Ronco JJ, Qayumi K, Dodek P, Wong H, Shepherd J, Fitzgerald JM, Ayas NT. The impact of prolonged continuous wakefulness on resident clinical performance in the intensive care unit: a patient simulator study. Crit Care Med. 2010; 38:766-70.
  • •Singh D, Edwards L, Tal-Singer R, et al. Sputum neutrophils as a biomarker in COPD: Findings from the ECLIPSE study. Respir Res 2010; 11:77.
  • •Spruit MA, Watkins ML, Edwards LD et al. Determinants of poor 6-min walking distance in patients with COPD: The ECLIPSE cohort. Respir Med. 2010; 104: 849-857.
  • •Yamada S, Richardson K, Tang M, Halaschek-Wiener J, Cook VJ, Fitzgerald JM, Elwood K, Marra F, Brooks-Wilson A. Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity.  Pharmacogenomics J. 2010; 10: 524-36.
  • •Town GI, Fitzgerald JM. Asthma: improved understanding and insights into the challenges of achieving asthma control. Thorax. 2010 Sep;65:758-9.
  • •Roig M, Eng JJ, Macintyre DL, Road JD, Fitzgerald JM, Burns J, Reid WD. Falls in people with chronic obstructive pulmonary disease: An observational cohort study. Respir Med. 2010 Sep 22.
  • •Roig M, Eng JJ, Macintyre DL, Road JD, Fitzgerald JM, Burns J, Reid WD. Falls in people with chronic obstructive pulmonary disease: An observational cohort study. Respir Med. 2010 Sep 22.
  • •Hanania NA, Müllerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EF, Rennard SI, Sharafkhaneh A; on behalf of the Evaluation of COPD. Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investigators. Determinants of Depression in the ECLIPSE COPD Cohort. Am J Respir Crit Care Med. 2010 Oct 1.
  • •Poureslami I, Rootman I, Doyle-Waters MM, Nimmon L, Fitzgerald JM. Health Literacy, Language, and Ethnicity-Related Factors in Newcomer Asthma Patients to Canada: A Qualitative Study. J Immigr Minor Health. 2010 Oct 12.
  • •Poureslami I, Rootman I, Doyle-Waters MM, Nimmon L, Fitzgerald JM. Health Literacy, Language, and Ethnicity-Related Factors in Newcomer Asthma Patients to Canada: A Qualitative Study. J Immigr Minor Health. 2010 Oct 12.
  • •Gauvreau GM, Boulet LP, Cockcroft DW, Fitzgerald JM, Carlsten C, Davis BE, Deschesnes F, Duong M, Durn BL, Howie KJ, Hui L, Kasaian MT, Killian KJ, Strinich TX, Watson RM, Y N, Zhou S, Raible D, O’Byrne PM. The Effects of IL-13 Blockade on Allergen-Induced Airway Responses in Mild Atopic Asthma. Am J Respir Crit Care Med. 2010 Nov 5.
  • •Louie K, Cheema R, Dodek P, Wong H, Wilmer A, Grubisic M, Fitzgerald JM, Ayas NT. Intensive nursing work schedules and the risk of hypoglycaemia in critically ill patients who are receiving intravenous insulin. Qual Saf Health Care. 2010 Dec;19:1-4.
  • •Quon BS, Fitzgerald JM, Lemière C, Shahidi N, Ducharme FM. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Cochrane Database Syst Rev. 2010 Dec 8;12:CD007524